|
1
|
Elhauge T, Schwier S, Hoag SW, Setnik B, Bianchi R, Altomare C, Toren P, Lindhardt K. Standardization of In Vitro Testing During Development of Abuse-Deterrent Opioids: Highlights From the Second and Third Category 1 Focus Group Meetings. Pain Pract 2019; 19:580-585. [PMID: 31286642 DOI: 10.1111/papr.12778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
| | | | - Stephen W Hoag
- Baltimore School of Pharmacy, University of Maryland, Baltimore, Maryland, U.S.A
| | - Beatrice Setnik
- Syneos Health, Raleigh, North Carolina, U.S.A.,Department of Toxicology and Pharmacology, University of Toronto, Toronto, Ontario, Canada
| | - Robert Bianchi
- Prescription Drug Research Center, Bradenton, Florida, U.S.A
| | | | - Penny Toren
- Vallon Pharmaceuticals, Inc, Philadelphia, Pennsylvania, U.S.A
| | | |
Collapse
|
|
2
|
Schwartz LP, Roma PG, Henningfield JE, Hursh SR, Cone EJ, Buchhalter AR, Fant RV, Schnoll SH. Behavioral economic demand metrics for abuse deterrent and abuse potential quantification. Drug Alcohol Depend 2019; 198:13-20. [PMID: 30861390 DOI: 10.1016/j.drugalcdep.2019.01.022] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/04/2018] [Revised: 12/14/2018] [Accepted: 01/27/2019] [Indexed: 12/29/2022]
Abstract
INTRODUCTION Behavioral economics provides a framework for quantifying drug abuse potential that can inform public health risk, clinical treatment, and research. Hypothetical purchase task (HPT) questionnaires may provide a low-cost and sensitive method by which to measure and predict the appeal of pharmaceutical drugs that differ by formulation. However, the validity of this type of analysis must be empirically established by comparing the "essential value" (EV) of different drugs across subgroups. PROCEDURES This pilot study used HPT assessments and the Exponential Model of Demand to quantify the EV of opioid medications-specifically, easily tampered formulations versus (vs.) abuse-deterrent formulations-in patients with a history of opioid abuse. MAIN FINDINGS Participants had more inelastic demand for opioid pills than for cigarettes and alcohol. Participants with experience manipulating pills (M group) had more inelastic demand for standard pills vs. participants with no manipulation experience (NM group), and the M group had a more elastic demand for the abuse-deterrent opioid pill than for the standard pill. There was no effect of formulation in the NM group and there was no difference in demand elasticity for abuse-deterrent pills between the two groups. There was a positive correlation between the EVs of different drugs, and between some behavioral economic indices and treatment variables. CONCLUSIONS Our results suggest that HPTs may provide a sensitive measure of abuse potential that can distinguish between different formulations in at-risk populations.
Collapse
Affiliation(s)
- Lindsay P Schwartz
- Institutes for Behavior Resources, 2104 Maryland Ave, Baltimore, MD, 21218, USA.
| | - Peter G Roma
- Behavioral Health and Performance Laboratory, Biomedical Research and Environmental Sciences Division, KBRwyle/NASA Johnson Space Center, Houston, TX, USA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 1800 Orleans St., Baltimore, MD, 21287, USA
| | - Jack E Henningfield
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 1800 Orleans St., Baltimore, MD, 21287, USA; Pinney Associates, 4800 Montgomery Ln #400, Bethesda, MD, 20814, USA
| | - Steven R Hursh
- Institutes for Behavior Resources, 2104 Maryland Ave, Baltimore, MD, 21218, USA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 1800 Orleans St., Baltimore, MD, 21287, USA
| | - Edward J Cone
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 1800 Orleans St., Baltimore, MD, 21287, USA; Pinney Associates, 4800 Montgomery Ln #400, Bethesda, MD, 20814, USA
| | | | - Reginald V Fant
- Pinney Associates, 4800 Montgomery Ln #400, Bethesda, MD, 20814, USA
| | - Sidney H Schnoll
- Pinney Associates, 4800 Montgomery Ln #400, Bethesda, MD, 20814, USA
| |
Collapse
|
|
4
|
Webster LR, Markman J, Cone EJ, Niebler G. Current and future development of extended-release, abuse-deterrent opioid formulations in the United States. Postgrad Med 2016; 129:102-110. [DOI: 10.1080/00325481.2017.1268902] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Lynn R. Webster
- Scientific Affairs, PRA Health Sciences, Salt Lake City, UT, USA
| | - John Markman
- Department of Neurosurgery, University of Rochester Medical Center, Rochester, NY, USA
| | | | - Gwendolyn Niebler
- Clinical Development and Medical Affairs, Egalet Corporation, Wayne, PA, USA
| |
Collapse
|